← Eichor
Condition: Prostate Cancer Patients Treated By Radiotherapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prostate Cancer Patients Treated By Radiotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05616650FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer,
Phase 2 · 6 location(s) · Northwestern University · NCT06244004Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
NA · 4 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04104529Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Phase 3 · 57 location(s) · Canadian Cancer Trials Group · NCT06235697Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI
Phase 2 · 3 location(s) · Ain Shams University · NCT07693075Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · 3 location(s) · University of Erlangen-Nürnberg Medical School · NCT07131956Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NA · 1 location(s) · Emory University · NCT04725903Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
Phase 3 · 5 location(s) · Stefan Carlsson · NCT04794777Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Phase 3 · 1 location(s) · Roswell Park Cancer Institute · NCT06563388Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT03237026This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surger
Phase 2 · 1 location(s) · University of Rochester · NCT05946824PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 · 1 location(s) · University of Nebraska · NCT07234981Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt
NA · 1 location(s) · University Hospital Freiburg · NCT06330909AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NA · 2 location(s) · Columbia University · NCT05351424Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07468903Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Pr
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06067269A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2 · 7 location(s) · Candel Therapeutics, Inc. · NCT07332000PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resist
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05805371Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NA · 1 location(s) · Hong Kong Sanatorium & Hospital · NCT07130682Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy
Phase N/A · 3 location(s) · Santa Chiara Hospital · NCT06473259Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07325721Long-term Better Than Short-term ADT With Salvage RT
Phase 2/Phase 3 · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04242017Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detecte
Phase 3 · 4 location(s) · UNICANCER · NCT06276465Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
NA · 2 location(s) · Region Skane · NCT06220435Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · 342 location(s) · ECOG-ACRIN Cancer Research Group · NCT04423211Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies
NA · 1 location(s) · University Hospital Heidelberg · NCT04083937SpaceOAR Post-Market Registry Study
Phase N/A · 7 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT07300631Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Do
NA · 1 location(s) · NYU Langone Health · NCT06542757Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
Phase N/A · 24 location(s) · Société Algérienne de Formation et Recherche en Oncologie · NCT07484971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.